Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -143.14x is in line with its 1-year average of -143.14x, around the middle of its 1-year range (-143.14x–-143.14x).
As of the fiscal period ended Saturday, June 30, 2018.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-143.14x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.67x
median of 372 covered companies
CURRENT VS SECTOR MEDIAN
-2968.44%
vs the sector median at left
Market Cap
$13.88M
Interest Coverage Ratio
-143.87x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.41M
Interest Coverage Ratio
-18.73x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.06M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.58M
Interest Coverage Ratio
-1.98x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.46M
Interest Coverage Ratio
-16.47x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.41M
Interest Coverage Ratio
N/A
TTM Avg
4.58x
3Y Avg
5.23x
5Y Avg
12.43x
Market Cap
$15.04M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.30M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IN8bio, Inc. (INAB) | $13.67M | -143.14x | N/A | N/A | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.88M | -143.87x | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.41M | -18.73x | N/A | N/A | N/A |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.06M | N/A | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.58M | -1.98x | N/A | N/A | N/A |
| Dare Bioscience, Inc. (DARE)vs › | $12.46M | -16.47x | N/A | N/A | N/A |
| IRIDEX Corporation (IRIX)vs › | $12.41M | N/A | 4.58x | 5.23x | 12.43x |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.04M | N/A | N/A | N/A | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | N/A | N/A | N/A | N/A |
| Lantern Pharma Inc. (LTRN)vs › | $11.87M | N/A | N/A | N/A | N/A |
Interest Coverage
-143.1x
Debt/Equity
0.12
Current Ratio
8.21
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2018-06-30 | -143.14x |
| 2018-03-31 | -143.14x |
